17422 Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices 

as a support for management decision 

making. 

Respondents: 55 State Developmental 

Disabilities Councils. 

ANNUAL BURDEN ESTIMATES

Instrument Number of respondents 

Number of responses per respondent Average burden 

hours per response 

Total burden 

hours 

Plan .................................................................................................. 55 1 367 20,185 

Estimated Total Annual Burden 

Hours: 

In compliance with the requirements 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2011–7157 Filed 3–28–11; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0002] 

Orthopaedic and Rehabilitation 

Devices Panel of the Medical Devices 

Advisory Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Orthopaedic and 

Rehabilitation Devices Panel of the 

Medical Devices Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the Agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on May 12, 2011, from 8 a.m. to 6 

p.m. 

Location: Hilton, Washington DC 

North/Gaithersburg, Salons A, B, C, and 

D, 620 Perry Pkwy., Gaithersburg, MD 

20877. 

Contact Person: Margaret McCabeJanicki, Food and Drug Administration, 

Center for Devices and Radiological 

Health, 10903 New Hampshire Ave., 

Bldg. 66, rm. 1535, Silver Spring, MD 

20993–0002, 301–796–7029, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area), and follow the 

prompts to the desired center or product 

area. Please call the Information Line for 

up-to-date information on this meeting. 

A notice in the Federal Register about 

last minute modifications that impact a 

previously announced advisory 

committee meeting cannot always be 

published quickly enough to provide 

timely notice. Therefore, you should 

always check the Agency’s Web site and 

call the appropriate advisory committee 

hot line/phone line to learn about 

possible modifications before coming to 

the meeting. 

Agenda: On May 12, 2011, the 

committee will discuss, make 

recommendations, and vote on 

information related to the premarket 

approval application (PMA) for the 

Augment Bone Graft, sponsored by 

Biomimetic Therapeutics, Inc. The 

intended use of the device is as an 

alternative bone grafting substitute to 

autologous bone graft in applications to 

facilitate fusion in the ankle and foot 

without necessitating an additional 

invasive procedure to harvest the graft. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ 

AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before May 5, 2011. Oral 

presentations from the public will be 

scheduled between approximately 1 

p.m. and 2 p.m. Those individuals 

interested in making formal oral 

presentations should notify the contact 

person and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation on or before April 25, 

2011. Time allotted for each 

presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by April 28, 2011. 

Persons attending FDA’s advisory 

committee meetings are advised that the 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices 17423 

Agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Ms. 

AnnMarie Williams, Conference 

Management Staff, 301–796–5966, at 

least 7 days in advance of the meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/ 

AdvisoryCommittees/ 

AboutAdvisoryCommittees/ 

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: March 23, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–7259 Filed 3–28–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with the requirements 

of Section 3506(c)(2)(A) of Public Law 

104–13, the Paperwork Reduction Act of 

1995, the Health Resources and Services 

Administration publishes summaries of 

proposed data collection projects for 

public comment. Comments are invited 

regarding the following: (a) The 

necessity of the proposed collection of 

information for the proper performance 

of the functions of the agency; (b) the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: Teaching Health 

Center Graduate Medical Education 

(GME) Program—NEW 

The Teaching Health Center Graduate 

Medical Education (GME) program 

(Section 340H of the Public Health 

Service Act) was established by Section 

5508 of Public Law 111–148, the Patient 

Protection and Affordable Care Act. The 

program supports training for primary 

care residents (including residents in 

family medicine, internal medicine, 

pediatrics, internal medicine-pediatrics, 

obstetrics and gynecology, psychiatry, 

general dentistry, pediatric dentistry, 

and geriatrics) in community-based 

ambulatory patient care settings. 

The statute provides that eligible 

Teaching Health Centers receive 

payments for both direct and indirect 

costs associated with training residents 

in community-based ambulatory patient 

care centers. Direct payments are 

designed to compensate eligible 

Teaching Health Centers for those 

expenses directly associated with 

resident training, while indirect 

payments are intended to compensate 

for the additional costs of training 

residents in such programs. Payments 

are made at the beginning of the funding 

cycle; however, the statute provides for 

a reconciliation process, through which 

overpayments may be recouped and 

underpayments may be adjusted at the 

end of the fiscal year. This data 

collection instrument will gather 

information relating to the numbers of 

residents in Teaching Health Center 

GME training programs in order to 

reconcile payments for both direct and 

indirect costs. 

The annual estimate of burden is as 

follows: 

Form Number of respondents 

Responses 

per respondent 

Total responses Hours per response Total burden 

hours 

Reconciliation form .............................................................. 11 1 11 10 110 

Total .............................................................................. 11 ........................ 11 10 110 

To request more information on this 

proposed project or to obtain a copy of 

the draft data collection plans and 

instruments, e-mail 

paperwork@hrsa.gov or call the HRSA 

Reports Clearance Officer at (301) 443– 

1129. 

E-mail comments to 

paperwork@hrsa.gov or mail the HRSA 

Reports Clearance Officer, Room 10–33, 

Parklawn Building, 5600 Fishers Lane, 

Rockville, MD 20857. Written comments 

should be received within 60 days of 

this notice. 

Dated: March 23, 2011. 

Reva Harris, 

Acting Director, Division of Policy and 

Information Coordination. 

[FR Doc. 2011–7317 Filed 3–28–11; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Laboratory Animal Welfare: Proposed 

Adoption and Implementation of the 

Eighth Edition of the Guide for the 

Care and Use of Laboratory Animals 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice of Extension of Public 

Comment Period. 

SUMMARY: The National Institutes of 

Health (NIH) is extending the period for 

public comments on (1) NIH’s adoption 

of the eighth edition of the Guide for the 

Care and Use of Laboratory Animals 

(Guide) as a basis for evaluation of 

institutional programs receiving or 

proposing to receive Public Health 

Service (PHS) support for activities 

involving animals; and (2) if NIH 

decides to adopt the eighth edition of 

the Guide, NIH’s proposed 

implementation plan, which would 

require that institutions complete at 

least one semiannual program and 

facility evaluation using the eighth 

edition of the Guide as the basis for 

evaluation by March 31, 2012. NIH will 

consider comments on (1) the adoption 

of the Guide and (2) the implementation 

plan. The notice on the proposed 

adoption and implementation plan for 

the eighth edition of the Guide was 

published in the Federal Register on 

February 24, 2011 (76 FR 10379). The 

comment period is extended by 30 days 

and thus will end on April 24, 2011. 


jlentini on DSKJ8SOYB1PROD with NOTICES